At the same time, abnormal activation of AKT is related to increased cancer cell proliferation, survival, and drug resistance (Jacobsen et al., 2017; Ediriweera et al., 2019; Wu Y. et al., 2022; Gu et al., 2022). This evidence concerns the gene AKT1 and cancer.